PRODUCT DESCRIPTION AND COMPOSITION
The
GMI NASAL CANNULA FOR OXYGEN THERAPY
consists of translucent
100% silicone tubing, with an open cylindrical-shaped distal end connecting to a
silicone arc, thereby forming two oxygen injection points along a nasal arc. Tubing
diameter varies according to the product code.
The proximal end of this tubing is connected using a bifurcated PVC (polyvinyl
chloride) connection with PVC extension set (tubing) located at its other end with
an external diameter of 6.40 mm for product codes 230-09 and 230-12 and 4.4 mm
for product codes 230-06, both with a total length of 2100 mm or 7500 mm and with
a cylindrical PVC connection at its end.
The part of the device that is positioned into the patient’s nostrils is anatomically
curved along the upper lip. The depth of the tubing inserted into the nasal can be
adjusted. Patients are able to move freely when the device is securely positioned.
The extension tubing possesses an internal device that ensures that the
administering of oxygen is never interrupted.
PURPOSE / RECOMMENDED USE
The
GMI NASAL CANNULA FOR OXYGEN THERAPY
is used to administer
oxygen or compressed air through the upper respiratory airways in patients
requiring such treatment.
It can also be used in patients with mild breathing difficulties, offering
supplementary oxygen to patients with difficulty in maintaining spontaneous
breathing.
INSTRUCTIONS FOR USE:
1. Open packaging while applying aseptic techniques as close as possible to the
moment at which the device will be used;
2. Products must be used under the direct supervision of a qualified and fully
trained health care professional.
3. Avoid applying excessive force during insertion;
4.
The cannula must be inserted in accordance with the institution’s standardized
procedures.
5. Place the patient in the Semi-
Fowler’s position;
6. Adjust oxygen flow;
7. Connect the end of the extension tubing to the oxygen source (tubing has an
interior design that prevents flow from being interrupted);
8. Adjust the depth of nasal tubing and place in nostrils, with anatomically curvature
resting on the upper lip;
09.
Adjust to the patient’s face, supporting the area behind the ears and adjusting
using the blue connection;
10. Ensure that the patient is comfortable.
Page. 02 / Rev.09
CONTRAINDICATIONS
Patients with facial burns and/or facial deformities.
WARNINGS AND PRECAUTIONS
1- This is a disposable product intended for use on a single patient.
2- Do not resterilize the product. Single use. Reprocessing is
prohibited.
3. Product must be used under the direct supervision of a qualified and fully
trained health care professional.
4. The sterility of this product is guaranteed if the packaging has not been
tampered with or damaged. Packaging preserving the product’s original condition
of sterility must only be opened in order to carry out the insertion procedure.
5. Precautions must be taken when using perforating or cutting
instruments since they may damage the external surface of the
product.
6. It is important to note that the techniques for use, special care taken with
the product, and removal may vary in accordance with the specific
circumstances of each usage;
7. Adhere to all medical recommendations and institutional standards regarding
the administering of oxygen.
8. Carry out frequent verifications of the permeability of nasal tubing.
9. An oxygen concentration between 1 and 6 L / min. is suggested.
10. It is preferable the the patient be connected to a saturation monitor.
11. Excessive pressure may damage the nasal mucusa. Introducing dry oxygen
for prolonged periods of time causes sequela in the nasal mucosa. Special care
must be taken at pressure points in order to avoid injury (ulcers caused by
pressure).
12. Do not use product after the expiration date.
13. Do not use product with patients under mechanical ventilation.
14. Product must not be used in endotracheal tubes or other respiratory
devices.
15. Non-flammable product, resistant to water and solar rays.
16. Carry out subsequent care in accordance with institutional/professional criteria.
17. Product must not be resterilized since they may
negatively affect the patient’s
health.
Page. 03 / Rev.09
